Macrovascular disease in diabetes: Is the mouse a suitable model?

Experimental and Clinical Endocrinology and Diabetes

Volumn 120, Issue 4, 2012, Pages 194-196

  Muller O J ^a   Katus, H A ^a   Backs, J ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

cardiovascular incidences; diabetes; metabolic features

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; LEPTIN; LEPTIN RECEPTOR; SOMATOMEDIN B; STREPTOZOCIN; TRIACYLGLYCEROL;

ATHEROSCLEROSIS; GENE; HYPERINSULINEMIA; HYPERLIPIDEMIA; INSULIN RESISTANCE; KNOCKOUT MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; TRANSGENIC MOUSE;

ANIMALS; DIABETIC ANGIOPATHIES; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT;

EID: 84860257829     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0032-1304580     Document Type: Review

References (29)

1. Hsueh W, Abel E D, Breslow J L et al. Recipes for creating animal models of diabetic cardiovascular disease. Circ Res: 2007; 100 1415 1427 (Pubitemid 46834754)
2. Wu K K, Huan Y. Diabetic atherosclerosis mouse models. Atherosclerosis: 2007; 191 241 249 (Pubitemid 46420447)
3. Schreyer S A, Vick C, Lystig T C et al. LDL receptor but not apolipoprotein E deficiency increases diet-induced obesity and diabetes in mice. Am J Physiol Endocrinol Metab: 2002; 282 E207 E214
4. MacLean P S, Bower J F, Vadlamudi S et al. Cholesteryl ester transfer protein expression prevents diet-induced atherosclerotic lesions in male db/db mice. Arterioscler Thromb Vasc Biol: 2003; 23 1412 1415 (Pubitemid 36994530)
5. Mirhashemi F, Scherneck S, Kluth O et al. Diet dependence of diabetes in the New Zealand Obese (NZO) mouse: total fat, but not fat quality or sucrose accelerates and aggravates diabetes. Exp Clin Endocrinol Diabetes: 2011; 119 167 171
6. Heinonen S E, Leppanen P, Kholova I et al. Increased atherosclerotic lesion calcification in a novel mouse model combining insulin resistance, hyperglycemia, and hypercholesterolemia. Circ Res: 2007; 101 1058 1067 (Pubitemid 350084983)
7. Zhang S, Picard M H, Vasile E et al. Diet-induced occlusive coronary atherosclerosis, myocardial infarction, cardiac dysfunction, and premature death in scavenger receptor class B type I-deficient, hypomorphic apolipoprotein ER61 mice. Circulation: 2005; 111 3457 3464 (Pubitemid 40923400)
8. Ingersoll M A, Spanbroek R, Lottaz C et al. Comparison of gene expression profiles between human and mouse monocyte subsets. Blood: 2010; 115 e10 e19
9. Goldberg I J, Dansky H M. Diabetic vascular disease: an experimental objective. Arterioscler Thromb Vasc Biol: 2006; 26 1693 1701 (Pubitemid 44305321)
10. Pirola L, Balcerczyk A, Okabe J et al. Epigenetic phenomena linked to diabetic complications. Nat Rev Endocrinol: 2010; 6 665 675
11. Rabbani N, Thornalley P J. Glyoxalase in diabetes, obesity and related disorders. Semin Cell Dev Biol: 2011; 22 309 317
12. Muhammad S, Bierhaus A, Schwaninger M. Reactive oxygen species in diabetes-induced vascular damage, stroke, and Alzheimer's disease. J Alzheimers Dis: 2009; 16 775 785
13. Wendt T, Harja E, Bucciarelli L et al. RAGE modulates vascular inflammation and atherosclerosis in a murine model of type 2 diabetes. Atherosclerosis: 2006; 185 70 77 (Pubitemid 43117552)
14. Otero P, Bonet B, Herrera E et al. Development of atherosclerosis in the diabetic BALB/c mice. Prevention with Vitamin E administration. Atherosclerosis: 2005; 182 259 265 (Pubitemid 41267193)
15. Kunjathoor V V, Wilson D L, LeBoeuf R C. Increased atherosclerosis in streptozotocin-induced diabetic mice. J Clin Invest: 1996; 97 1767 1773 (Pubitemid 26105486)
16. Park L, Raman K G, Lee K J et al. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat Med: 1998; 4 1025 1031 (Pubitemid 28417334)
17. Kako Y, Masse M, Huang L S et al. Lipoprotein lipase deficiency and CETP in streptozotocin-treated apoB-expressing mice. J Lipid Res: 2002; 43 872 877 (Pubitemid 34602608)
18. Reaven P, Merat S, Casanada F et al. Effect of streptozotocin-induced hyperglycemia on lipid profiles, formation of advanced glycation endproducts in lesions, and extent of atherosclerosis in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol: 1997; 17 2250 2256 (Pubitemid 28057129)
19. Renard C B, Kramer F, Johansson F et al. Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions. J Clin Invest: 2004; 114 659 668 (Pubitemid 39578756)
20. Merat S, Casanada F, Sutphin M et al. Western-type diets induce insulin resistance and hyperinsulinemia in LDL receptor-deficient mice but do not increase aortic atherosclerosis compared with normoinsulinemic mice in which similar plasma cholesterol levels are achieved by a fructose-rich diet. Arterioscler Thromb Vasc Biol: 1999; 19 1223 1230 (Pubitemid 29227641)
21. Phillips J W, Barringhaus K G, Sanders J M et al. Rosiglitazone reduces the accelerated neointima formation after arterial injury in a mouse injury model of type 2 diabetes. Circulation: 2003; 108 1994 1999 (Pubitemid 37296545)
22. Smith J D, James D, Dansky H M et al. In silico quantitative trait locus map for atherosclerosis susceptibility in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol: 2003; 23 117 122 (Pubitemid 36091635)
23. Schreyer S A, Wilson D L, LeBoeuf R C. C57BL/6 mice fed high fat diets as models for diabetes-accelerated atherosclerosis. Atherosclerosis: 1998; 136 17 24 (Pubitemid 28341437)
24. Dansky H M, Charlton S A, Sikes J L et al. Genetic background determines the extent of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol: 1999; 19 1960 1968 (Pubitemid 29379929)
25. Gruen M L, Saraswathi V, Nuotio-Antar A M et al. Plasma insulin levels predict atherosclerotic lesion burden in obese hyperlipidemic mice. Atherosclerosis: 2006; 186 54 64
26. Wu K K, Wu T J, Chin J et al. Increased hypercholesterolemia and atherosclerosis in mice lacking both ApoE and leptin receptor. Atherosclerosis: 2005; 181 251 259 (Pubitemid 41019605)
27. Hasty A H, Shimano H, Osuga J et al. Severe hypercholesterolemia, hypertriglyceridemia, and atherosclerosis in mice lacking both leptin and the low density lipoprotein receptor. J Biol Chem: 2001; 276 37402 37408
28. Castellani L W, Goto A M, Lusis A J. Studies with apolipoprotein A-II transgenic mice indicate a role for HDLs in adiposity and insulin resistance. Diabetes: 2001; 50 643 651 (Pubitemid 32195231)
29. Federici M, Hribal M L, Menghini R et al. Timp3 deficiency in insulin receptor-haploinsufficient mice promotes diabetes and vascular inflammation via increased TNF-alpha. J Clin Invest: 2005; 115 3494 3505 (Pubitemid 43121837)